These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17646593)

  • 1. Tissue plasminogen activator-induced reperfusion injury after stroke revisited.
    Hermann DM; Matter CM
    Circulation; 2007 Jul; 116(4):363-5. PubMed ID: 17646593
    [No Abstract]   [Full Text] [Related]  

  • 2. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.
    Hafeez F; Razzaq MA; Levine RL; Ramirez MA
    J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.
    Isayev Y; Conahan E; Mathiesen C; Jenny D; Castaldo J
    Neurology; 2010 Nov; 75(20):1853-4; author reply 1854. PubMed ID: 21121100
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits.
    Lapchak PA
    Brain Res; 2007 Sep; 1167():123-8. PubMed ID: 17673188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of lysis percentage via thromboelastography for tissue plasminogen activator-induced symptomatic intracranial hemorrhage.
    Gilbert BW; Dingman JS; Huffman JB
    Am J Emerg Med; 2021 May; 43():31-34. PubMed ID: 33493994
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC; Gasche Y
    Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleveland Clinic system doubles use of i.v. tPA.
    Perform Improv Advis; 2004 Jan; 8(1):4, 1. PubMed ID: 15011498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
    Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot-buster proves safe, effective when given during first three hours after a stroke.
    Rep Med Guidel Outcomes Res; 2000 Mar; 11(6):7-8. PubMed ID: 11770508
    [No Abstract]   [Full Text] [Related]  

  • 12. Safer thrombolysis for acute ischemic stroke: is early recanalization the key?
    Tanne D; Levine SR
    Neurology; 2008 Oct; 71(17):1300-1. PubMed ID: 18936422
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal subdural hematoma following tissue plasminogen activator treatment for acute ischemic stroke.
    Kim SH; Choi SH; Song EC; Rha JH; Kim SR; Park HC
    J Neurol Sci; 2008 Oct; 273(1-2):139-41. PubMed ID: 18635196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke.
    Choi D
    Neurobiol Dis; 2000 Oct; 7(5):552-8. PubMed ID: 11042076
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 16. Life after SAINT.
    Hallevi H; Aronowski J
    Int J Stroke; 2007 Nov; 2(4):241-2. PubMed ID: 18705923
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroprotection in acute ischemic stroke: are we there yet?
    Shuaib A
    Int J Stroke; 2006 May; 1(2):100-1. PubMed ID: 18706053
    [No Abstract]   [Full Text] [Related]  

  • 19. Stroke. The critical first hours.
    Mayo Clin Health Lett; 2008 Oct; 26(10):4-5. PubMed ID: 19004109
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue plasminogen activator: beyond thrombolysis.
    Benarroch EE
    Neurology; 2007 Aug; 69(8):799-802. PubMed ID: 17709713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.